Clinical Trials Browser

Interventional × bemarituzumab × 90 days × Clear all

NCT05052801 2026-05-27

FORTITUDE-101

Phase 3 Completed

Gastrointestinal

Stomach Neoplasms

NCT07146919 2026-04-23

ANGELICA

Phase 1/2 Withdrawn

Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT07470840 2026-03-24

SBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell Carcinoma

Phase 2 Not yet recruiting

Carcinoma, Renal Cell